Press Releases April 6, 2026 08:00 PM

First Western Financial, Inc. to Report First Quarter 2026 Financial Results on Thursday, April 23

First Western Financial, Inc. Announces Q1 2026 Earnings Release and Conference Call Date

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
MYFW

First Western Financial, Inc., a financial services holding company traded on NASDAQ as MYFW, announced it will report its first quarter 2026 financial results on April 23, 2026, followed by a management conference call on April 24, 2026. The company provides wealth management and private trust banking services across several western U.S. states.

First Western Financial, Inc. to Report First Quarter 2026 Financial Results on Thursday, April 23
MYFW
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • First Western Financial will release Q1 2026 financial results on April 23, 2026, after market close.
  • A conference call will be held on April 24, 2026, for management to discuss results with investors and analysts.
  • First Western operates in multiple western U.S. states, offering integrated wealth management and private trust banking services.

DENVER, April 07, 2026 (GLOBE NEWSWIRE) -- First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in Denver, Colorado (“First Western”), announced today that it will release financial results for its first quarter ended March 31, 2026 after the markets close on Thursday, April 23, 2026.

Management will hold a conference call at 10:00 a.m. Mountain Time/12:00 p.m. Eastern Time on Friday, April 24, 2026, to discuss First Western’s financial results. Analysts and investors may participate in the question-and-answer session. The conference call will be webcast live on the News & Events page of First Western’s investor relations website.

Participants on the conference call will need to click on the Telephone Access link provided below, register for the conference call, and then they will receive the dial-in number and a personalized PIN code.

Conference Call and Webcast Information:

Date: Friday, April 24, 2026

Time: 10:00 a.m. MT / 12:00 p.m. ET

Telephone Access: https://register-conf.media-server.com/register/BIa19f2c66af854a57b25db1c34f017817

Webcast Access: A live webcast will be available on the News & Events page of First Western’s investor relations website. An archived version of the webcast will be available in the same location shortly after the live call has ended.

About First Western Financial, Inc.

First Western is a financial services holding company headquartered in Denver, Colorado, with operations in Colorado, Arizona, Wyoming, California, and Montana. First Western Financial, Inc. and its subsidiaries provide a fully integrated suite of wealth management services on a private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning and investment management products and services. First Western’s common stock is traded on the NASDAQ Global Select Market under the symbol “MYFW.” For more information, please visit www.myfw.com.

Contacts:
Financial Profiles, Inc.
Tony Rossi
310-622-8221

[email protected]
[email protected]


Risks

  • Financial results may not meet market expectations, impacting stock price and investor sentiment.
  • Economic or regional market conditions in western U.S. states may affect company performance.
  • Uncertainties related to wealth management and banking sectors, including regulatory or interest rate changes.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026